Jabra Enhance Select 200 vs Signia Pure C&G BCT IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Select 200
The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earns a B grade with a SoundScore of 3.9/5 in our lab testing, ranking in the top 35% of OTC devices. At $1,695, it sits at the higher end of the OTC market and has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. This behind-the-ear device delivers its strongest performance in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.67 points above the OTC category average. Own-voice comfort is another highlight at 3.4/5, which is 0.89 points above average, meaning wearers are less likely to experience the bothersome "talking in a barrel" sensation. Music streaming scores 2.6/5, which is 0.68 points above the category average, though still mixed in absolute terms. The device shows some limitations in challenging listening situations. Speech in noise performance is low at 1.4/5, sitting slightly below the category average. Feedback handling scores a strong 4.0/5 in absolute terms, though this falls 0.54 points below the OTC average of 4.54/5. The Enhance Select 200 includes modern conveniences like rechargeable batteries and streaming compatibility with both iPhone and Android devices, plus hands-free calling capability. However, budget-conscious shoppers should note that several devices in this price range—including the Lucid Tala and Audicus Omni 2—achieve higher scores, and alternatives like the Lucid Engage offer similar sound quality at lower prices. This device is best suited for listeners who prioritize clear speech in quieter settings and natural own-voice quality over performance in noisy environments.
Choice

Signia Pure C&G BCT IX
The Signia Pure C&G BCT IX is a premium prescription behind-the-ear hearing aid released in 2025, priced at $3,398. In our lab testing, it earned an A grade with a SoundScore of 4.4/5, placing it in the top 39% of the 36 prescription hearing aids we've tested. This device shows notable strengths in speech clarity and own-voice comfort. Speech in quiet scored 3.8/5, which is 0.47 points above the category average—a solid result for everyday conversations. Speech in noise measured 2.5/5, above the category average by 0.58 points, though only mixed in absolute terms, meaning challenging listening environments may still present difficulty. Own-voice comfort is a standout at 3.8/5, a full 1.05 points above average, suggesting reduced occlusion effects that many wearers find bothersome. Feedback handling scored 4.2/5—strong in absolute terms, though 0.51 points below the category average of 4.71/5. Music streaming at 2.7/5 is essentially on par with category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Consumers shopping in this premium price tier should note that several alternatives offer higher overall scores, including the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5). For those prioritizing own-voice comfort and solid speech performance in quieter settings, the Pure C&G BCT IX delivers, but buyers seeking top-tier noise performance may want to compare options.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit